Related Experiment Video
Updated: Aug 9, 2026
07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Amiodarone-induced hyperthyroidism and a thyroid nodule
C N Morris1, G H Tan, S A Smith
1Division of Infectious Disease & Internal Medicine, Columbia Presbyterian Medical Center, New York, NY, USA.
Summary
Amiodarone therapy can cause thyrotoxicosis (overactive thyroid). Thyroid nodules require specific preoperative scanning to guide surgical treatment for amiodarone-induced hyperthyroidism.
Area of Science:
- Endocrinology
- Cardiology
- Nuclear Medicine
Background:
- Amiodarone is an effective antiarrhythmic drug.
- Amiodarone therapy is associated with thyroid dysfunction, including thyrotoxicosis.
- Thyroid nodules can complicate the management of amiodarone-induced thyrotoxicosis.
Purpose of the Study:
- To present two cases of thyrotoxicosis linked to amiodarone.
- To discuss how thyroid nodules influence the management of amiodarone-induced thyrotoxicosis.
Main Methods:
- Case report of two patients with amiodarone-induced hyperthyroidism.
- Review of the underlying mechanisms of amiodarone-induced thyrotoxicosis.
- Development of a decision-making strategy for managing patients with thyroid nodules.
Main Results:
- Amiodarone-induced thyrotoxicosis results from direct toxicity or excess iodine.
- Surgical intervention may be necessary when amiodarone discontinuation or medical management fails.
- Preoperative thyroid scanning is crucial to differentiate between a hyperfunctioning nodule and diffuse disease, guiding surgical extent.
Conclusions:
- Preoperative thyroid scanning is essential for surgical planning in amiodarone-induced hyperthyroidism with a solitary thyroid nodule.
- Findings guide surgeons to perform subtotal thyroidectomy for diffuse disease or lobectomy for a hyperfunctioning nodule.
More Related Videos
Related Concept Videos
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...